GLP-1 Care Through Perimenopause and Menopause

The midlife metabolic shift is real

Many women feel that their body changed almost overnight in their forties, and the science backs that up. Across the menopause transition, body composition shifts toward more fat and less lean mass, and weight tends to creep up in a way that pre-menopausal habits no longer control². Falling and fluctuating estrogen is part of why fat redistributes toward the abdomen, raising metabolic risk even when the number on the scale moves only modestly⁴.

Where GLP-1 medicines fit

GLP-1 receptor agonists act on appetite and insulin response rather than on estrogen, so they address the metabolic side of the transition, not the hormonal one directly. In the STEP 1 obesity trial, once-weekly semaglutide produced a mean weight reduction of about 15%, with a substantial share of participants being midlife women³. For many women, the most sensible framing is GLP-1 care as one tool alongside — not instead of — a conversation about menopausal hormone therapy, sleep, strength training and cardiovascular risk¹.

Choosing a provider in this stage of life

Because perimenopause layers hormonal symptoms on top of metabolic ones, oversight and labs matter more here, not less. A provider that checks thyroid and metabolic markers, understands where you are in the transition, and can coordinate with the clinician managing any hormone therapy is worth more than the cheapest sticker price. That is why our ranking weights clinical oversight and hormonal suitability heavily — see the full Luna Fit Score methodology, and our reviews of hormone- and longevity-aware programs.

The cautions that matter

GLP-1 medicines are not appropriate during pregnancy, which still matters in perimenopause because ovulation can be unpredictable rather than absent. They can also affect the absorption of oral medications. As always, this is educational information, not medical advice — decisions in this stage of life are best made with a clinician who can see your whole picture¹.